HMTXF
Price:
$0.04175
Market Cap:
$11.87M
Hemostemix Inc. is a biotechnology firm dedicated to the research, development, and commercialization of stem cell therapies derived from blood, aimed at addressing a range of medical conditions. These innovative treatments are uniquely developed from a patient's own blood, providing a non-invasive source of therapeutic cells. Leading their pipeline is ACP-01, an autologous cell therapy currently undergoing Phase II clinical trials in both Canada and the United States. This product targets critical limb ischemia, along with various heart and peripheral arterial diseases. The company is also actively developing other cellular products, including synergistic cell populations and neural cell pr...[Read more]
Industry
Biotechnology
IPO Date
2016-01-07
Stock Exchange
OTC
Ticker
HMTXF
According to Hemostemix Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.24. This represents a change of -63.62% compared to the average of 0.65 of the last 4 quarters.
The mean historical Current Ratio of Hemostemix Inc. over the last ten years is 1.48. The current 0.24 Current Ratio has changed 1.50% with respect to the historical average. Over the past ten years (40 quarters), HMTXF's Current Ratio was at its highest in in the September 2017 quarter at 11.94. The Current Ratio was at its lowest in in the December 2019 quarter at 0.02.
Average
1.48
Median
0.27
Minimum
0.02
Maximum
11.41
Discovering the peaks and valleys of Hemostemix Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 30.65%
Maximum Annual Current Ratio = 11.41
Minimum Annual Increase = -98.30%
Minimum Annual Current Ratio = 0.02
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 0.49 | 36.84% |
| 2024 | 0.36 | 228.16% |
| 2023 | 0.11 | -38.54% |
| 2022 | 0.18 | 37.72% |
| 2021 | 0.13 | -81.01% |
| 2020 | 0.68 | 2.72% |
| 2019 | 0.02 | -98.30% |
| 2018 | 1.42 | -87.59% |
| 2017 | 11.41 | 30.65% |
| 2016 | 0.04 | -96.18% |
The current Current Ratio of Hemostemix Inc. (HMTXF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0.32
5-year avg
0.25
10-year avg
1.48
Hemostemix Inc.’s Current Ratio is greater than Nymox Pharmaceutical Corporation (0.09), less than Devonian Health Group Inc. (1.47), less than HOOKIPA Pharma Inc. (3.93), less than Algorae Pharmaceuticals Limited (17.99), greater than EOM Pharmaceuticals Holdings, Inc. (0.08), less than Sirona Biochem Corp. (0.55), less than Oxford BioDynamics Plc (0.88), less than Inhibitor Therapeutics, Inc. (3.60), greater than Quest PharmaTech Inc. (0.02), greater than Cell Source, Inc. (0.02),
| Company | Current Ratio | Market cap |
|---|---|---|
| 0.09 | $9.17M | |
| 1.47 | $29.62M | |
| 3.93 | $14.40M | |
| 17.99 | $13.87M | |
| 0.08 | $21.52M | |
| 0.55 | $1.63M | |
| 0.88 | $6.39M | |
| 3.60 | $14.67M | |
| 0.02 | $5.07M | |
| 0.02 | $36.93M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Hemostemix Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Hemostemix Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Hemostemix Inc.'s Current Ratio?
How is the Current Ratio calculated for Hemostemix Inc. (HMTXF)?
What is the highest Current Ratio for Hemostemix Inc. (HMTXF)?
What is the 3-year average Current Ratio for Hemostemix Inc. (HMTXF)?
What is the 5-year average Current Ratio for Hemostemix Inc. (HMTXF)?
How does the current Current Ratio for Hemostemix Inc. (HMTXF) compare to its historical average?